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ABSTRACT
Humans obtain vitamin D from conversion of 7-dehydrocholesterol in the skin by ultraviolet
B (UVB) radiation or from dietary sources. As the radiation level is insufficient in winter, vitamin D
deficiency is common at higher latitudes. We assessed whether vernal solar UVB radiation at
latitudes 61°N and 67°N in Finland has an impact on serum 25-hydroxyvitamin D [S-25(OH)D]
concentrations. Twenty-seven healthy volunteers participated in outdoor activities in snow-
covered terrain for 4–10 days in March or April, with their face and hands sun-exposed. The
personal UVB doses and S-25(OH)D levels were monitored. A mean UVB dose of 11.8 standard
erythema doses (SED) was received during an average of 12.3 outdoor hours. The mean S-25(OH)
D concentration in subjects with a baseline concentration below 90.0 nmol/L (n=13) increased
significantly, by 6.0 nmol/L from an initial mean of 62.4 nmol/L (p<0.001), whereas in those with a
basal concentration above 90.0 nmol/L (n=12) it decreased significantly, by 6.7 nmol/L from a
mean of 116.9 nmol/L (p<0.01). To conclude, only 7% of total body surface area was exposed to
vernal sunlight and this was capable of increasing S-25(OH)D levels in subjects with a baseline
level below 90 nmol/L but not in those with higher levels.
ARTICLE HISTORY
Received 20 October 2016
Revised 6 December 2016
Accepted 6 December 2016
KEYWORDS
25(OH)D; vitamin D;
ultraviolet; UVB; spring
Introduction
Humans obtain vitamin D either from conversion of 7-
dehydrocholesterol in the skin by ultraviolet B (UVB) radia-
tion, or from dietary sources. Depending on the latitude,
time of the year and the mode of subsistence, dietary
sources can be the major form, especially for Northern
peoples [1]. Vitamin D is hydroxylated in the liver to the
circulating form, 25-hydroxyvitamin D [25(OH)D], which is
the best indicator of vitamin D status. Vitamin D insuffi-
ciency has been linked to chronic skeletal [2] and extra-
skeletal diseases such as obesity and type 2 diabetes
mellitus [3,4]. Low S-25(OH)D levels are common in
Scandinavians in winter, because the available sunlight
is not capable of inducing vitamin D synthesis and their
dietary intake of vitamin D is often suboptimal [5,6].
Although recent national policies have succeeded in
increasing vitamin D intake in Finland, roughly a quarter
of men and half of women fail to reach the recommended
dietary intake [7]. It seems, however, that native popula-
tions that have lived at high latitudes for hundreds of
generations have adapted to low S-25(OH)D levels by
developing compensating mechanisms [1,8].
The lowest S-25(O)D levels in subjects living at high
latitudes are typically measured between February and
April [9–12]. In theory, there is enough sunlight for
vitamin D synthesis from early March onwards at a
latitude of 61°N [13]. A previous Norwegian study at
latitude 68°N supported the theoretical calculations,
since individual subjects with low S-25(OH)D responded
to solar UV radiation already in early March when just
the face was exposed, but the study cohort was very
small [10]. Another Danish study at latitude 56°N
showed an increase in S-25(OH)D by 8 April when
more skin than the face and hands was exposed [11].
At higher latitudes, cold weather prevents people from
exposing more skin than the face and hands during
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March and April, but exposure of these areas would
seem to suffice to increase S-25(OH)D levels [10,14].
Reflections from snow-covered terrain can substantially
increase the UVB dose received by the skin during out-
door activities [15], which can result in a higher UVB
dose than measured previously [13]. Since previous
studies are scarce, our goal was to determine whether
the solar UVB radiation level at high latitudes in Finland
in March and April is capable of raising S-25(OH)D
concentrations when only the face and hands are
exposed.
Material and methods
Subjects
Twenty-seven healthy volunteers were enrolled, the
inclusion criteria being age 18 years or older and avoid-
ance of solarium visits, phototherapy, holidays in low
latitudes and vitamin D supplementation during a 1-
month washout period prior to the trial and during it.
Further exclusion criteria were pregnancy, previous skin
cancer, intake of photosensitising drugs and Fitzpatrick
´s skin phototype 1 [16]. Recruitment began on 1
February 2013 and the trial was coordinated from the
Department of Dermatology at Päijät-Häme Central
Hospital, terminating in data collection on 22 April
2014. Vitamin D intake at the onset was estimated by
means of a 3-day food frequency questionnaire.
Twenty-five subjects completed the trial (Table 1), two
having been disqualified for failing to follow the expo-
sure regimen. The protocol was approved by the Ethics
Committee of Tampere University Hospital (Reg. No.
R12266), and all the volunteers gave their informed
consent in advance.
Sample size calculation
The trial was designed to show an increase in S-25(OH)
D of at least 15 nmol/L with an α-value of 0.05 and a β-
value of 0.80. An assumed SD of 15.5 nmol/L for the
S-25(OH)D analyses was used. Accordingly, it was
considered necessary that 16 volunteers should com-
plete the trial.
Ultraviolet radiation exposures
The scheduled monitored ultraviolet radiation (UVR)
exposures were implemented in Sodankylä (67°N) and
Lahti (61°N) in March and April 2013 and 2014 in snow-
covered terrain (Table 2). The participants were
instructed to expose their hands and face without
using a sunscreen. In addition to the scheduled expo-
sures, they were encouraged to perform outdoor activ-
ities in their own time.
Ultraviolet radiation measurements
The participants wore UVB dosimeters (VioSpor blue
line Type II, BioSense, Bornheim, Germany) attached
to their upper arms or wrists with straps to detect
the dose received by the skin [17,18]. These dosi-
meters detect radiation ranging from 1.0 to 55 stan-
dard erythema doses (SED). The ambient solar UVR
data were obtained from NILU-UV multichannel
radiometer [19] recordings made at the Finnish
Meteorological Institute’s Arctic Research Centre
(FMI-ARC) in Sodankylä, or were measured locally
using a Robertson-Berger-type broadband UV meter
(Solar Light Model 501 UV meter s/n 635; Solar Light
Co. Inc., Glenside, PA, USA). The NILU-UV radiometer
was calibrated by Innovation Nilu AS by reference to
the National Institute of Standards and Technology
(NIST) (Gaithersburg, MD, USA) and was placed on
the roof of the FMI-ARC sounding station to collect
data in the form of 1-minute averages. The
Robertson-Berger meter is calibrated annually by
the Radiation and Nuclear Safety Authority, Helsinki,
Finland, also by reference to NIST. Its calibration
uncertainty (2σ) is 8%. The meter was placed on a
high roof near the UV exposure area. As there were
no ambient UVR measurements available for Lahti,
use was made of UVR data obtained at Jokioinen
(61°N) with the FMI’s Brewer spectroradiometer [20],
which was calibrated by reference to the MIKES-Aalto
National Standards Laboratory. Comparisons with the
European reference spectroradiometer have shown
that discrepancies are less than ±5% (http://www.
pmodwrc.ch/wcc_uv/).
Serum 25-hydroxyvitamin D measurements
The blood samples for 25(OH)D analyses were taken in
general in the morning on the first exposure day (range
Table 1. Demographic data, daily vitamin D intake, baseline
S-25(OH)D concentration and personal ultraviolet B radiation
dose.
N=25
Male/Female 8/17
Mean age, years (range) 43 [22–71]
Mean body mass index, kg m−2, mean±SD (range) 23.9±4.5
Fitzpatrick’s skin type II/III 7/18
Vitamin D intake, µg/d, mean±SD 8.5±3.2
Baseline S-25(OH)D (nmol/L), mean±SD 88.6±32.6
UV dosimeter (SED), mean±SD (range) 11.8±4.9 (2.4–23.2)
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0–5 days before), and 1–4 days after the last day. The
samples were centrifuged and serum was stored at –20°
C and analysed for 25(OH)D by electro-chemilumines-
cence binding assay (Roche Diagnostics, Mannheim,
Germany) with a coefficient of variation ≤7%.
Statistics
The strength of the adjusted relationship between
baseline S-25(OH)D concentrations and their change
after the solar UVR exposure period was described by
means of a partial correlation coefficient. The signifi-
cance of the change was calculated using the paired-
samples t-test, and Pearson’s chi-square test was used
when comparing nominal data. All the analyses were
performed using STATA 14 (StataCorp LP, College
Station, TX).
Results
The mean daily vitamin D intake of the 25 subjects was
8.5±3.2 µg (Table 1) and the mean baseline S-25(OH)D
concentration was 88.6±32.6 nmol/L. The mean perso-
nal total UVB dose was 11.8±4.9 SED during a mean of
12.3±4.3 hours spent outdoors (Tables 1 and 2). The
mean available ambient daily UVB dose was 9.4 SED
and the maximum UV indices were 1.1–2.7 depending
on the period. The mean S-25(OH)D concentration
showed a slight non-significant decrease of 0.1 nmol/L
(p=0.971) after the exposures, but the baseline concen-
trations had an inverse relationship with the percentage
change after exposure when adjusted for age, body
mass index and Fitzpatrick’s skin phototype (r=−0.51,
p=0.011) (Figure 1).
The baseline S-25(OH)D concentrations below
90.0 nmol/L increased after exposure, whereas those
that were above 90.0 nmol/L decreased, in all subjects
except one (Figure 2, Table 3). In the <90 nmol/L group
(n=13) the S-25(OH)D increased by 6.0 nmol/L (95% CI
2.8–9.2, p<0.001) from an initial mean of 62.4 nmol/L
and that in the >90 nmol/L group (n=12) decreased by
6.7 nmol/L (95% CI −10.3 to −3.0, p<0.01) from
116.9 nmol/L (Figure 2, Table 3). The total UVB doses
received by the volunteers correlated with the numbers
of hours spent outdoors (r=0.612, p=0.02), but no cor-
relation was found between the UVB doses and the
change in S-25(OH)D concentrations. There were no
differences in demographic data or UVB doses detected
between the subjects with a S-25(OH)D value below or
above 90 nmol/L (Table 3). Four subjects with baseline
S-25(OH)D below 90 nmol/L and six subjects with base-
line S-25(OH)D above 90 nmol/L had used vitamin D
supplementation prior the 1-month washout period
with a mean daily dose of 13.3±7.3 µg (range
5–25 µg). The mean dose did not differ significantly
between the groups (p=0.081). The baseline S-25(OH)
D levels in males (83.3 nmol/L) and females (91.0 nmol/
L) did not show a significant difference (p=0.593).
Discussion
Our results indicate that vernal UVB radiation at a high
latitude (61° or 67°) between 17 March and 20 April is
capable of raising S-25(OH)D levels in subjects with
baseline levels below 90 nmol/L, whereas levels above
that decrease. The mean baseline level 88.6 nmol/L was
higher than expected at high latitudes in early spring.
This could be attributed to national food fortification
policy and improved dietary vitamin D intake [7], use of
vitamin D supplementation or holidays in low latitudes
prior the washout period. In our previous study [21],
where S-25(OH)D levels were monitored from October
to May in subjects with no vitamin D supplementation
during the winter, nor any exposure to UVR, the mean
concentration in early April was lower, 65.8 nmol/L.
The increase of lower S-25(OH)D levels early in
spring is a solid finding, but the decreasing trend in
higher levels is unexpected, since all subjects were
Table 2. Ultraviolet radiation exposure locations, time periods, exposure instructions and average daily available ultraviolet B
radiation doses.
Group Location Dates
Daily available UVB
radiation dose (SED),
mean (range)
Maximum
UV index
Personal UVB
radiation dose
(SED), mean ± SD
N = 21
Total hours spent outdoors
between 10AM and 3PM,
mean ± SD
I (N=4) Sodankylä, Finland (67°N, 26°E) 17.3.–26.3.20131 5.0 (4.1–6.2)3 1.2 20.56 19.3±3.0
II (N=6) Sodankylä, Finland (67°N, 26°E) 29.3.–1.4.20131 7.1 (6.8–7.3)5 1.2 11.1±7.6 12.2±3.8
III (N=5) Sodankylä, Finland (67°N, 26°E) 7.4.–17.4.20142 9.6 (4.5–13.2)3 2.3 10.9±1.7 11.0±3.2
IV (N=3) Sodankylä, Finland (67°N, 26°E) 18.4.–20.4.20141 13.0 (10.4–15.3)3 2.7 11.2±6.9 9.0±1.7
V (N=7) Lahti, Finland (61°N, 25°E) 2.4.–12.4.20132 12.1 (9.1–15.4)4 2.7 11.97 10.7±2.5
Mean 11.8±4.9 12.3±4.3
1Maximum exposure during holiday outdoor activities. 2Walking outdoors for 1 hour daily at noon during working days. 3NILU-UV measurements from FMI-
ARC, 4Spectroradiometer measurements from FMI, Jokioinen Observatory. 5Local Robertson-Berger meter. 6Only one subject had a dosimeter. 7One
dosimeter for the whole group.
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Figure 1. Relationship of changes in S-25(OH)D concentrations after the solar ultraviolet radiation exposure period to baseline
concentrations.
R adjusted for age, body mass index and Fitzpatrick’s skin type, p=0.011.
Lower S-25(OH)D group (<90 nmol L-1) Higher S-25(OH)D group (>90 nmol L-1)
Figure 2. Changes in S-25(OH)D concentrations in the lower S-25(OH)D group (<90 nmol/L) and in the higher S-25(OH)D group
(>90 nmol/L).
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exposed to a source of vitamin D. It could be that in
subjects with higher levels, the S-25(OH)D gained
from previous vitamin D sources keeps decreasing
due to the half-life of S-25(OH)D, and this decrease
exceeds the amount of S-25(OH)D produced by ver-
nal UVB. Interestingly, we further analysed data from
our previous study [21] and observed similar kinetics
in the control subjects – higher values kept on
decreasing from early April to early May, whereas
lower values began to increase. In fact, this phenom-
enon could also be due to an effective homeostatic
S-25(OH)D control system for ensuring its stable avail-
ability. The points at which this regulation takes place
evidently include (i) the liver concentration of 25-
hydroxylase, which converts vitamin D to 25(OH)D,
and (ii) catabolism of 25(OH)D to breakdown pro-
ducts in the liver and in other tissues [22]. The
inverse relationship between the change in S-25(OH)
D concentration and its baseline concentration in our
subjects might in part be caused by this regulation. A
similar phenomenon has been demonstrated also in
other high latitude studies in the Nordic countries
[10,12,23].
The homeostatic control system exists because of
the health risks of having a S-25(OH)D concentration
too low or high. It is generally agreed upon that a
U-shaped response curve exists between the S-25(OH)
D concentration and various disease risks. In a Swedish
study, an approximately 50% higher total mortality rate
was observed among men in the lowest 10%
(≤46 nmol/L) and the highest 5% (≥98 nmol/L) of
plasma 25(OH)D concentrations compared with inter-
mediate concentrations [24]. S-25(OH)D below 40 nmol/
L and above 60 nmol/L have shown to increase the risk
of prostate cancer in the Finnish population, and both
high and low levels seem to promote premature ageing
[25]. A transnational study in women reported
increased mortality for seven types of cancer (endome-
trial, oesophageal, gastric, kidney, non-Hodgkin’s lym-
phoma, pancreatic, ovarian) in subjects with S-25(OH)D
below 45 nmol/L and above 124 nmol/L [26]. A pooled
meta-analysis including eight case-control studies
reported an increased pancreatic cancer risk in subjects
with S-25(OH)D above 100 nmol/L [27]. The
Framingham Heart Study concluded that cardiovascular
disease risk increases with S-25(OH)D below 50 nmol/L
and above 62.5 nmol/L, and the NHANES III study found
a higher all-cause mortality rate for S-25(OH)D above
122.5 nmol/L [28].
Like most heritable characteristics, vitamin D meta-
bolism varies among human populations. Populations
that have lived at high latitudes for hundreds of gen-
erations have had time to adapt to limited opportu-
nities for vitamin D synthesis. This kind of adaptation
has been shown in the Inuit of Northern Canada and
Greenland. Despite low S-25(OH)D levels and a calcium-
deficient diet, Inuit have normal blood levels of calcium.
They seem to absorb calcium more effectively, perhaps
due to their different vitamin D receptor genotype pre-
valence [8]. They also seem to convert vitamin D at a
higher rate to its most active form [1]. These metabolic
differences may explain why Amerindian women have
lower S-25(OH)D levels than do Euro-American women,
while having higher bone mass density until meno-
pause [29,30].
There is some worrisome evidence that native
Northern people can experience effects of vitamin D
toxicity at relatively low levels. A recent study of
Greenland Inuit found increasing S-25(OH)D levels to
be positively associated with increased fasting- and 2-
hour plasma glucose and HbA1c, and decreased beta-
cell function [31]. This dose-response curve was very
different from the one seen in European populations.
Although a homeostatic mechanism seems to keep
S-25(OH)D levels within a zone of minimal health risks
[22], this homeostasis could be circumvented through
daily ingestion of high vitamin D supplementation
doses. This is a relatively novel situation for our species,
and the risks could be higher for those who have
adapted to low S-25(OH)D levels.
Table 3. Demographic data and changes in S-25(OH)D concentration after solar exposure in subjects with low (<90.0 nmol/L) and
high (>90.0 nmol/L) baseline S-25(OH)D concentrations.
Low S-25(OH)D (N=13) High S-25(OH)D (N=12) p-value
Male/Female 5/8 3/9 0.637
Mean age, years (range) 43 [22–63] 44 [24–71] 0.888
Mean body mass index, kg m−2, mean±SD (range) 25.0±5.2 22.3±3.1 0.204
Fitzpatrick’s skin type II/III 2/11 5/7 0.202
Vitamin D intake, µg/d, mean±SD 7.6±1.8 9.4±4.1 0.182
Baseline S-25(OH)D (nmol/L), mean±SD 62.4±15.8* 116.9±18.9**
Change of the S-25(OH)D (nmol/L), mean (95% CI) 6.0 (2.8 to 9.2)* −6.7 (−10.3 to −3.0)**
S-25(OH)D after the exposure (nmol/L), mean±SD 68.4±20.3* 110.3±21.2**
UV dosimeter (SED), mean±SD 11.4±5.0 12.4±5.0 0.642
Hours spent outdoors between 10 am and 3 pm, mean±SD 11.4±3.3 13.2±5.1 0.303
*Significant increase (p<0.001) **Significant decrease (p<0.01).
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As cutaneous vitamin D synthesis depends on the
UVB dose received in the skin, factors that affect UVB
wavelength and irradiance have a direct influence on
vitamin D synthesis. The most relevant factor for
Northern inhabitants is the solar zenith angle, which
depends on the time of day, season of the year and
latitude. As the zenith angle increases, the UVB radia-
tion has to travel a longer distance through the atmo-
sphere and has more chance of being absorbed or
scattered, which reduces the amount reaching the
skin [32]. At latitude 52°N no cutaneous vitamin D
synthesis is detectable from October to March, a phe-
nomenon described as the “vitamin D winter” [32]. The
length of the “winter” is not constant, however, but
varies with levels of ozone, cloudiness and aerosols
[33]. Ozone levels can reduce or increase the latitude
of the “vitamin D winter” by 10°, and extend or shorten
its duration by up to 2 months [33]. The lowest seasonal
S-25(OH)D concentrations in subjects living at high lati-
tudes are typically measured between February and
April [9–12]. In theory, cutaneous vitamin D production
is possible at latitude 61°N from early March [13], an
estimate based on UV spectroradiometer irradiance
measurements on a horizontal surface, but a snowy
surface can further increase the subject’s UVB dose
due to reflections between the ground and sky and
direct reflections from the ground to vertical surfaces
[14]. The albedo of snow varies between 0.5 and 0.7
[34,35] and the effect is most pronounced for vertical
surfaces such as the face [15]. All the outdoor activities
performed by the present subjects took place in snow-
covered fields, which probably increased the measured
personal UVB doses significantly.
The UV exposures were received on the face and
hands, the exposure of which has been shown to
suffice to increase S-25(OH)D levels [10,14]. A previous
study performed in Denmark (56°N) showed an
increase in S-25(OH)D levels by 8 April, when more
skin than the face and hands was exposed [11]. In a
Norwegian study (68°N) exposure of the facial area to
UVR between 8 February and 12 April yielded no
increase in mean S-25(OH)D levels [9], being in agree-
ment with our findings. Interestingly, subjects with
S-25(OH)D <30 nmol/L responded in early March
[10], whereas in our study the cut-off limit was
90 nmol/L. Our cut-off limit was higher probably
because of a larger exposed skin area (4% vs. 7%),
longer minimum daily exposure time (20 min vs.
60 min) and study period that extended further
towards the spring (20 April). Contrary to the previous
study [10], in our subjects the increase of S-25(OH)D
levels below 90 nmol/L was highly significant and
strengthens the evidence of the vitamin D effects of
vernal UVR. However, the optimal S-25(OH)D level can
differ between populations, and thus the findings of
the present study are not directly generalisable.
To conclude, vernal solar UVR at high latitudes
seems to increase S-25(OH)D concentrations in subjects
with a baseline level below 90 nmol/L when only the
face and hands, i.e. 7% of total body surface area, are
exposed. The declining trend seen in volunteers with a
high baseline level above 90 nmol/L is interesting, and
could reflect an especially active homeostatic S-25(OH)
D control system in caucasoid people living at high
latitudes. This phenomenon should be studied in
more detail in future trials.
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